相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
Alba Rodriguez-Garcia et al.
NATURE COMMUNICATIONS (2021)
Thinking Differently about Cancer Treatment Regimens
Jeff Settleman et al.
CANCER DISCOVERY (2021)
Positron Emission Tomography Imaging of Macrophages in Cancer
Candace C. Parker et al.
CANCERS (2021)
Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy
Xiuman Zhou et al.
BIOMOLECULES (2021)
CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
Sophia Fotiou Magkouta et al.
CANCERS (2021)
Targeting tumor-associated macrophages to synergize tumor immunotherapy
Xiaonan Xiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
Siyuan Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Stromal PD-1+ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma
Lu Chen et al.
HUMAN PATHOLOGY (2020)
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Shamir Cassim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clement Anfray et al.
CELLS (2020)
A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade
Christopher E. Rudd
SCIENCE IMMUNOLOGY (2020)
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
Laura Strauss et al.
SCIENCE IMMUNOLOGY (2020)
First in man study of [18F] fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis
Nicki J. F. Verweij et al.
SCIENTIFIC REPORTS (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
Antonio Maccio et al.
SCIENTIFIC REPORTS (2020)
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
Aaron R. Lim et al.
ELIFE (2020)
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia et al.
ADVANCED MATERIALS (2020)
Tackling TAMs for Cancer Immunotherapy: It's Nano Time
Yishun Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
Megan M. Tu et al.
COMMUNICATIONS BIOLOGY (2020)
The hypoxia-lactate axis tempers inflammation
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2020)
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
Daniele Biasci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
Luca Cassetta et al.
CANCER CELL (2019)
Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
Huizhong Xiong et al.
CANCER RESEARCH (2019)
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
Ying Zhu et al.
GUT (2019)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis
J. D. Jones et al.
NEOPLASIA (2019)
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Johanna Wagner et al.
CELL (2019)
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
Hiroshi Yano et al.
IMMUNOLOGY (2019)
The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
Jiajing Cai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria et al.
TRENDS IN IMMUNOLOGY (2019)
Epigenetics in cancer therapy and nanomedicine
Annalisa Roberti et al.
CLINICAL EPIGENETICS (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
Re-education of macrophages as a therapeutic strategy in cancer
Joanna Kowal et al.
IMMUNOTHERAPY (2019)
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Xaria X. Li et al.
JOURNAL OF IMMUNOLOGY (2019)
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors
Emily A. Irey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MicroRNAs as Molecular Switches in Macrophage Activation
Graziella Curtale et al.
FRONTIERS IN IMMUNOLOGY (2019)
Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages
Marco Orecchioni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression
Kritika Saxena et al.
BIOMOLECULES (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
Di Lu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes
Morten Norgaard Andersen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
Gang Shi et al.
MOLECULAR THERAPY (2019)
Molecular Repolarisation of Tumour-Associated Macrophages
Floris J. van Dalen et al.
MOLECULES (2019)
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
Jorge Blando et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The folate receptor as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis
Durga M. S. H. Chandrupatla et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
The yin and yang of imaging tumor associated macrophages with PET and MRI
Sudip Mukherjee et al.
THERANOSTICS (2019)
Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map
Jennifer Huynh et al.
NATURE REVIEWS CANCER (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Context-dependent roles of complement in cancer
Lubka T. Roumenina et al.
NATURE REVIEWS CANCER (2019)
The renaissance of complement therapeutics
Daniel Ricklin et al.
NATURE REVIEWS NEPHROLOGY (2018)
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors
Nils Pemberton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Jenny D. Beebe et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade
Natalie J. Neubert et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Jennifer L. Guerriero
TRENDS IN MOLECULAR MEDICINE (2018)
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages
Amber E. de Groot et al.
Oncotarget (2018)
Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
Pooja Dhupkar et al.
CANCER MEDICINE (2018)
Targeting veGF/veGFR to Modulate Antitumor immunity
Ju Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Transcriptional Regulation of Macrophages Polarization by MicroRNAs
Heng Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting Macrophages in Cancer: From Bench to Bedside
Ashleigh R. Poh et al.
FRONTIERS IN ONCOLOGY (2018)
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Si-Qi Qiu et al.
CANCER TREATMENT REVIEWS (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
Terry R. Medler et al.
CANCER CELL (2018)
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
Matthew M. Gubin et al.
CELL (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
Gene Regulatory Network Modeling of Macrophage Differentiation Corroborates the Continuum Hypothesis of Polarization States
Alessandro Palma et al.
FRONTIERS IN PHYSIOLOGY (2018)
Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors
David Argyle et al.
FRONTIERS IN IMMUNOLOGY (2018)
Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
Ekaterini Platanitis et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epigenetic mechanisms as a new approach in cancer treatment: An updated review
Masoumeh Fardi et al.
GENES & DISEASES (2018)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Hiroshi Maeda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Complement in cancer: untangling an intricate relationship
Edimara S. Reis et al.
NATURE REVIEWS IMMUNOLOGY (2018)
TGF-β signalling in tumour associated macrophages
Alexei Gratchev
IMMUNOBIOLOGY (2017)
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung et al.
IMMUNOLOGICAL REVIEWS (2017)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance
Bhargavi Pulluri et al.
PHARMACOLOGICAL RESEARCH (2017)
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Sean P. Arlauckas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
CSF-1R Inhibitor Development: Current Clinical Status
Florent Peyraud et al.
CURRENT ONCOLOGY REPORTS (2017)
A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis
Daniel Ajona et al.
CANCER DISCOVERY (2017)
Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
Jingjiao Zhou et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Paulo C. Rodriguez et al.
FRONTIERS IN IMMUNOLOGY (2017)
Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
Haoran Zha et al.
ONCOIMMUNOLOGY (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response
Birgit Lehmann et al.
SCIENCE IMMUNOLOGY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Macrophage polarization in response to epigenetic modifiers during infection and inflammation
Urmi Patel et al.
DRUG DISCOVERY TODAY (2017)
TAMeless traitors: macrophages in cancer progression and metastasis
Shweta Aras et al.
BRITISH JOURNAL OF CANCER (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
L. O'Leary et al.
ONCOGENE (2016)
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Erlinda M. Gordon et al.
ADVANCES IN THERAPY (2016)
Silencing of CD47 and SIRPα by Polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMA-differentiated THP-1 cells
Gizem Bener et al.
BMC IMMUNOLOGY (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
The Multifaceted Role of Perivascular Macrophages in Tumors
Claire E. Lewis et al.
CANCER CELL (2016)
Combining Epigenetic and Immunotherapy to Combat Cancer
Katherine B. Chiappinelli et al.
CANCER RESEARCH (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Mathias Wenes et al.
CELL METABOLISM (2016)
Inhibiting macrophage PI3Kγ to enhance immunotherapy
Wei Zheng et al.
CELL RESEARCH (2016)
Abandoning M1/M2 for a Network Model of Macrophage Function
Matthias Nahrendorf et al.
CIRCULATION RESEARCH (2016)
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Yumeng Mao et al.
CLINICAL CANCER RESEARCH (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Protection of host cells by complement regulators
Christoph Q. Schmidt et al.
IMMUNOLOGICAL REVIEWS (2016)
CD163+ M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma
Qinglin Han et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
The impact of hypoxia on tumor-associated macrophages
Anne-Theres Henze et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
TLR4, TLR7/8 agonist-induced miR-146a promotes macrophage tolerance to MyD88-dependent TLR agonists
M. Abu Nahid et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation
Theodore S. Kapellos et al.
MEDIATORS OF INFLAMMATION (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Reflections on immunological nomenclature: in praise of imperfection
Alberto Mantovani
NATURE IMMUNOLOGY (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions
Ferdinando Pucci et al.
SCIENCE (2016)
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
Daniela F. Quail et al.
SCIENCE (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Catherine A. Evans et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Epigenetic dynamics of monocyte-to-macrophage differentiation
Stefan Wallner et al.
EPIGENETICS & CHROMATIN (2016)
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen et al.
CANCER DISCOVERY (2016)
Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression
Yu Wang et al.
CANCER DISCOVERY (2016)
Functional TRAIL receptors in monocytes and tumor-associated macrophages: a possible targeting pathway in the tumor microenvironment
Manuela Liguori et al.
ONCOTARGET (2016)
The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization
Florian Finkernagel et al.
ONCOTARGET (2016)
TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype
Fan Zhang et al.
ONCOTARGET (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Post-Sepsis State Induces Tumor-Associated Macrophage Accumulation through CXCR4/CXCL12 and Favors Tumor Progression in Mice
Jose M. Mota et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
Rikke B. Holmgaard et al.
ONCOIMMUNOLOGY (2016)
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
Alexander S. Baras et al.
ONCOIMMUNOLOGY (2016)
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ping-Chih Ho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
Takuya Shiota et al.
PLOS ONE (2016)
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways
Ling-Ling An et al.
SCIENTIFIC REPORTS (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Kaustav Das Gupta et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity
Xianfeng Wang et al.
JCI INSIGHT (2016)
A Journey with Elie Metchnikoff: From Innate Cell Mechanisms in Infectious Diseases to Quantum Biology
Fabrice Merien
FRONTIERS IN PUBLIC HEALTH (2016)
Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems
Juan Jose Vaquero et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17 (2015)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Rony Dahan et al.
CANCER CELL (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Yinan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin
Yoshiyuki Hattori et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy The 2015 Lasker-DeBakey Clinical Medical Research Award
James P. Allison
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Thibault Voron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET Imaging of Tumor-Associated Macrophages with Zr-89-Labeled High-Density Lipoprotein Nanoparticles
Carlos Perez-Medina et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Tamas Roszer
MEDIATORS OF INFLAMMATION (2015)
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis
C. Ning et al.
MUCOSAL IMMUNOLOGY (2015)
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
W. D. Tap et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Noninvasive imaging of immune responses
Mohammad Rashidian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells
Erik Arner et al.
SCIENCE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Biology of Hypoxia
Paul N. Span et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
Allison S. Harney et al.
CANCER DISCOVERY (2015)
Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer
Yanshuang Li et al.
SCIENTIFIC REPORTS (2015)
M-CSF from Cancer Cells Induces Fatty Acid Synthase and PPARβ/δ Activation in Tumor Myeloid Cells, Leading to Tumor Progression
Jonghanne Park et al.
CELL REPORTS (2015)
Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice
Paulina Pathria et al.
ONCOIMMUNOLOGY (2015)
The origin and function of tumor-associated macrophages
Yang Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Novel Markers to Delineate Murine M1 and M2 Macrophages
Kyle A. Jablonski et al.
PLOS ONE (2015)
Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
Jing Lu et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic pathways in cancer immunosurveillance: molecular mechanisms and prospects for therapy
Britnie R. James et al.
RESEARCH AND REPORTS IN BIOCHEMISTRY (2015)
CD47 signaling pathways controlling cellular differentiation and responses to stress
David R. Soto-Pantoja et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Complement and macrophage crosstalk during process of angiogenesis in tumor progression
M. Afzal Khan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Nadine Jetten et al.
ANGIOGENESIS (2014)
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
M. D'Incalci et al.
BRITISH JOURNAL OF CANCER (2014)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Nesrine I. Affara et al.
CANCER CELL (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
Damya Laoui et al.
CANCER RESEARCH (2014)
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
Stephen Mok et al.
CANCER RESEARCH (2014)
Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
Surya Kumari Vadrevu et al.
CANCER RESEARCH (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Macrophage polarization: the epigenetic point of view
Jan Van den Bossche et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
VEGF Signaling in Cancer Treatment
Daniela Sia et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Transcriptomic analysis of mononuclear phagocyte differentiation and activation
David A. Hume et al.
IMMUNOLOGICAL REVIEWS (2014)
M1 and M2 Macrophages: The Chicken and the Egg of Immunity
Charles D. Mills et al.
JOURNAL OF INNATE IMMUNITY (2014)
An atlas of active enhancers across human cell types and tissues
Robin Andersson et al.
NATURE (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Imaging macrophages with nanoparticles
Ralph Weissleder et al.
NATURE MATERIALS (2014)
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Naofumi Mukaida et al.
MEDIATORS OF INFLAMMATION (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
C. Marcelo Diaz-Montero et al.
SEMINARS IN ONCOLOGY (2014)
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
Zhong-Yu Yuan et al.
ONCOTARGETS AND THERAPY (2014)
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
Meiying Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Molecular mechanisms that influence the macrophage M1-M2 polarization balance
Nan Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas
Jason M. Fritz et al.
FRONTIERS IN IMMUNOLOGY (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice
Erika Zonari et al.
BLOOD (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
Koji Ohnishi et al.
CANCER SCIENCE (2013)
Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
Hidetoshi Nitta et al.
CLINICAL CANCER RESEARCH (2013)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
TGF-beta signaling and epithelial-mesenchymal transition in cancer progression
Yoko Katsuno et al.
CURRENT OPINION IN ONCOLOGY (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes
Daigo Hashimoto et al.
IMMUNITY (2013)
Targeting tumor-infiltrating macrophages to combat cancer
Roheena Z. Panni et al.
IMMUNOTHERAPY (2013)
Expression profiles of miRNAs in polarized macrophages
Yingying Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Hydrazinocurcumin Encapsuled Nanoparticles Re-Educate Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression (Publication with Expression of Concern. See vol. 14, 2019)
Xiwen Zhang et al.
PLOS ONE (2013)
The Ratios of CD8+ T Cells to CD4+ CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
Claudia C. Preston et al.
PLOS ONE (2013)
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
Chao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Beyond Stem Cells: Self-Renewal of Differentiated Macrophages
Michael H. Sieweke et al.
SCIENCE (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
E. L. Pearce et al.
SCIENCE (2013)
Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis
Yoony Y. J. Gent et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Macrophages: Gatekeepers of Tissue Integrity
Yonit Lavin et al.
CANCER IMMUNOLOGY RESEARCH (2013)
The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
Qing Chang et al.
NEOPLASIA (2013)
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells
Debbie C. Strachan et al.
ONCOIMMUNOLOGY (2013)
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
Anne-Katrine Bonde et al.
BMC CANCER (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Akihiro Tsuyada et al.
CANCER RESEARCH (2012)
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
Guangwen Ren et al.
CELL STEM CELL (2012)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Influence of low oxygen tensions on macrophage polarization
Maria M. Escribese et al.
IMMUNOBIOLOGY (2012)
Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells
Yusuke Ohara et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers
Xiaochun Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
Emmanuel L. Gautier et al.
NATURE IMMUNOLOGY (2012)
Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development
S. M. Pyonteck et al.
ONCOGENE (2012)
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
Hiroaki Shime et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Christian Schulz et al.
SCIENCE (2012)
Differential macrophage programming in the tumor microenvironment
Brian Ruffell et al.
TRENDS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Shannon E. Mullican et al.
GENES & DEVELOPMENT (2011)
Anti-VEGF Therapy in Breast and Lung Mouse Models of Cancers
Di Domenico Marina et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
S. K. Martin et al.
LEUKEMIA (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
Seth B. Coffelt et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis
Lin Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Comparison of gene expression profiles between human and mouse monocyte subsets
Molly A. Ingersoll et al.
BLOOD (2010)
The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
Junliang Ma et al.
BMC CANCER (2010)
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al.
CANCER RESEARCH (2010)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
Kiyomi Takaishi et al.
CANCER SCIENCE (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
Jian Zhang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis
Norihiko Takeda et al.
GENES & DEVELOPMENT (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Hongxia Z. Imtiyaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
Xin Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Monocyte Chemotactic Protein 1 Promotes Lung Cancer-Induced Bone Resorptive Lesions In Vivo
Zhong Cai et al.
NEOPLASIA (2009)
Behavior of Endogenous Tumor-Associated Macrophages Assessed In Vivo Using a Functionalized Nanoparticle
Antoine Leimgruber et al.
NEOPLASIA (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Cancer related inflammation: The macrophage connection
Antonio Sica et al.
CANCER LETTERS (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Samuel Kim et al.
CANCER RESEARCH (2008)
Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice
Sean P. Dineen et al.
CANCER RESEARCH (2008)
From phagocyte diversity and activation to probiotics: Back to Metchnikoff
Alberto Mantovani
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Elie Metchnikoff: Father of natural immunity
Siamon Gordon
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
Paola Allavena et al.
IMMUNOLOGICAL REVIEWS (2008)
Inhibition of self engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
Richard K. Tsai et al.
JOURNAL OF CELL BIOLOGY (2008)
Re-educating tumor-associated macrophages by targeting NF-κB
Thorsten Hagemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Historical insights into cytokines
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Function, structure and therapeutic potential of complement C5a receptors
P. N. Monk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Targeting hypoxia cell signaling for cancer therapy
Giovanni Melillo
CANCER AND METASTASIS REVIEWS (2007)
The folate receptor: What does it promise in tissue-targeted therapeutics?
Marcela D'Alincourt Salazar et al.
CANCER AND METASTASIS REVIEWS (2007)
CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases
Matt J. Craig et al.
CANCER AND METASTASIS REVIEWS (2006)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
In vivo CD40 ligation can induce T cell-independent antitumor effects that involve macrophages
Hillary D. Lum et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
SK Biswas et al.
BLOOD (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4
TQ Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Blockade of transforming growth factor-β signaling suppresses progression of androgen-independent human prostate cancer in nude mice
FH Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
P Allavena et al.
CANCER RESEARCH (2005)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression
A Mantovani et al.
EUROPEAN JOURNAL OF CANCER (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors
J Wyckoff et al.
CANCER RESEARCH (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily
AG Eliopoulos et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
E Hirsch et al.
SCIENCE (2000)
Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction
Z Li et al.
SCIENCE (2000)
分享论文
